A new study published in the British Medical Journal (BMJ) has found that some hormonal contraceptives, particularly those ...
Dr. Ebenezer Quainoo is a medical professional whose career has been defined by a dedicated approach to healthcare.
The study revealed the risk of developing venous thromboembolisms from various types of synthetic hormones, providing ...
QLS‑111 is a novel topical formulation using Qlaris Bio’s ATP-sensitive potassium channel modulator platform. QLS-111 lowers ...
A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...
Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results